Oct 23, 2024, 14:18
Sam Klempner: DKN-01 with Tislelizumab and Chemotherapy in Advanced Gastric or GEJ Adenocarcinoma
Sam Klempner, Associate Professor at Harvard Medical School, shared on X:
“Adding to the ever growing approaches in GEA
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or GEJ Adenocarcinoma: DisTinGuish.”
Authors: Samuel J. Klempner, Mohamad Bassam Sonbol, Zev A. Wainberg, Hope Elizabeth Uronis, Vi K. Chiu, Aaron James Scott, Syma Iqbal, Mohamedtaki Abdulaziz Tejani, Vincent Chung, Melissa C. Stilian, Mathis Thoma, Ying Zhang, Michael H. Kagey, Jason Baum, Cynthia A. Sirard, Rachel A. Altura, Jaffer A. Ajani.
Aaron James Scott
cancer
Cynthia A. Sirard
gastric cancer
GEJ adenocarcinoma
Hope Elizabeth Uronis
Jaffer A Ajani
Jason Baum
Mathis Thoma
Melissa C. Stilian
Michael H. Kagey
Mohamad Bassam Sonbol
Mohamedtaki Abdulaziz Tejani
OncoDaily
Oncology
Rachel A. Altura
Sam Klempner
Samuel J Klempner
Syma Iqbal
Tislelizumab
Vi K. Chiu
Vincent Chung
Ying Zhang
Zev A. Wainberg
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43